Researchers sought to determine whether MSD HSCT or auto-HSCT would have advantages over chemotherapy in post-remission treatment for patients with AML.

Metformin, a widely used and affordable diabetes drug, could prevent a form of acute myeloid leukemia in people at high risk ...

A new study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains ...

Fms-like tyrosine kinase 3 (FLT3) is one of the most commonly mutated genes in acute myeloid leukemia (AML). FLT3 internal tandem duplication (ITD) plays an important role in shaping the clinical ...

Aug. 21, 2024 — An international team of scientists has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth. AML cells prevent the synthesis of proteins that ...

10-year-old Rachel Simon of Hazlet was diagnosed with acute myeloid leukemia and needs a bone marrow transplant. Several donor drives are scheduled throughout April and May in New Jersey to find a ...

For example, investigational agents undergoing development for use in AML include FLT3 inhibitors, polo-like kinase inhibitors, farnesyltransferase inhibitors, HSP90 inhibitors, Mdm2 inhibitors ...

1 Many cases are acute, and the causative agent can be demonstrated ... The bone marrow exhibited a failure of maturation in the white-cell series beyond the myelocyte stage.